Utilization of cardiac troponin assays in adult and pediatric populations: Guideline recommendations vs. reality

Clinical Biochemistry

Volumn 48, Issue 18, 2015, Pages 1213-1218

  Saenger, Amy K ^a   Haymond, Shannon ^b  

^a MAYO CLINIC   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Biomarkers; High sensitivity troponin; Pediatrics; Troponin; Utilization

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; MYOGLOBIN; NATRIURETIC FACTOR; TROPONIN I; BIOLOGICAL MARKER; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC TROPONIN 1 CLIA; CARDIAC TROPONIN 1 CLIA KIT; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONSENSUS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEALTH CARE SURVEY; HUMAN; HYPOTHESIS; IMMUNOASSAY ANALYZER; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL LITERATURE; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TURNAROUND TIME; VERBAL COMMUNICATION; WORLD HEALTH ORGANIZATION; BIOASSAY; BLOOD; CHEST PAIN; CLINICAL CHEMISTRY; FEMALE; LABORATORY; MALE; MYOCARDIAL INFARCTION; PROCEDURES; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTILIZATION;

ADULT; BIOLOGICAL ASSAY; BIOMARKERS; CHEMISTRY, CLINICAL; CHEST PAIN; CHILD; CREATINE KINASE, MB FORM; FEMALE; HUMANS; LABORATORIES; MALE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES; TROPONIN I; TROPONIN T; UNITED STATES;

EID: 84949032673     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.08.008     Document Type: Article

References (24)

1. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 2000, 36:959-969.
2. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 2012, 60:1581-1598.
3. Thygesen K., Alpert J.S., White H.D., Joint ESCAAHAWHFTFftRoMI Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 2007, 50:2173-2195.
4. Apple F.S., Jesse R.L., Newby L.K., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin. Chem. 2007, 53:547-551.
5. Pulkki K., Suvisaari J., Collinson P., et al. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin. Chem. Lab. Med.: CCLM/FESCC 2009, 47:227-234.
6. Collinson P.O., van Dieijen-Visser M.P., Pulkki K., et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin. Chem. 2012, 58:305-306.
7. Layfield C., Rose J., Alford A., et al. Effectiveness of practices for improving the diagnostic accuracy of non ST elevation myocardial infarction in the emergency department: a laboratory medicine best practices systematic review. Clin. Biochem. 2015, 48:204-212.
8. Apple F.S., Ler R., Murakami M.M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin. Chem. 2012, 58:1574-1581.
9. Apple F.S., Jaffe A.S., Collinson P., et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin. Biochem. 2015, 48:201-203.
10. Le R.D., Kosowsky J.M., Landman A.B., Bixho I., Melanson S.E., Tanasijevic M.J. Clinical and financial impact of removing creatine kinase-MB from the routine testing menu in the emergency setting. Am. J. Emerg. Med. 2015, 33:72-75.
11. Newby L.K., Roe M.T., Chen A.Y., et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J. Am. Coll. Cardiol. 2006, 47:312-318.
12. Saenger A.K., Jaffe A.S. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008, 118:2200-2206.
13. Amsterdam E.A., Wenger N.K., Brindis R.G., et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014, 64:e139-e228.
14. Baron J.M., Lewandrowski K.B., Kamis I.K., Singh B., Belkziz S.M., Dighe A.S. A novel strategy for evaluating the effects of an electronic test ordering alert message: optimizing cardiac marker use. J. Pathol. Inform. 2012, 3:3.
15. Safdar B., Bezek S.K., Sinusas A.J., et al. Elevated CK-MB with a normal troponin does not predict 30-day adverse cardiac events in emergency department chest pain observation unit patients. Crit. Pathw. Cardiol. 2014, 13:14-19.
16. Brown J.L., Hirsh D.A., Mahle W.T. Use of troponin as a screen for chest pain in the pediatric emergency department. Pediatr. Cardiol. 2012, 33:337-342.
17. Liesemer K., Casper T.C., Korgenski K., Menon S.C. Use and misuse of serum troponin assays in pediatric practice. Am. J. Cardiol. 2012, 110:284-289.
18. Thankavel P.P., Mir A., Ramaciotti C. Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen. Cardiol. Young 2014, 24:283-289.
19. Collinson P.O., Heung Y.M., Gaze D., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin. Chem. 2012, 58:219-225.
20. Koerbin G., Potter J.M., Abhayaratna W.P., et al. Longitudinal studies of cardiac troponin I in a large cohort of healthy children. Clin. Chem. 2012, 58:1665-1672.
21. McKie P.M., Heublein D.M., Scott C.G., et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin. Chem. 2013, 59:1099-1107.
22. Bailey D., Colantonio D., Kyriakopoulou L., et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin. Chem. 2013, 59:1393-1405.
23. Koerbin G., Potter J.M., Abhayaratna W.P., Telford R.D., Hickman P.E. The distribution of cardiac troponin I in a population of healthy children: lessons for adults. Clin. Chim. Acta 2013, 417:54-56.
24. Lane J.R., Ben-Shachar G. Myocardial infarction in healthy adolescents. Pediatrics 2007, 120:e938-e943.